Bioton SA
WSE:BIO
Bioton SA
Research & Development
Bioton SA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioton SA
WSE:BIO
|
Research & Development
-zł4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-3%
|
|
|
M
|
Mabion SA
WSE:MAB
|
Research & Development
-zł254k
|
CAGR 3-Years
72%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
R
|
Read Gene SA
WSE:RDG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Genomed SA
WSE:GEN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
U
|
Urteste SA
WSE:URT
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Synthaverse SA
WSE:SVE
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bioton SA
Glance View
BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
See Also
What is Bioton SA's Research & Development?
Research & Development
-4m
PLN
Based on the financial report for Sep 30, 2025, Bioton SA's Research & Development amounts to -4m PLN.
What is Bioton SA's Research & Development growth rate?
Research & Development CAGR 10Y
-3%
Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for Bioton SA have been 10% over the past three years , 7% over the past five years , and -3% over the past ten years .
